|
|
The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.
In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.
More than 4.4billion prescriptions were dispensed within the United States in 2016.
This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.
Women are 50% to 75% more likely than men to experience an adverse drug reaction.